bromodeoxyuridine has been researched along with Cholangitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, N; de Jong, MC; Jiang, L; Li, F; Li, N; Li, Q; Mao, H; Pawlik, TM; Zhou, Y | 1 |
| Hatano, E; Honda, K; Terao, R; Uehara, T; Yamamoto, M; Yamaoka, Y | 1 |
| Hatano, E; Iimuro, Y; Nitta, T; Terao, R; Uehara, T; Yamamoto, N; Yamaoka, Y; Yoshida, M | 1 |
3 other study(ies) available for bromodeoxyuridine and Cholangitis
| Article | Year |
|---|---|
Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cholangitis; Collagen Type I; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; fas Receptor; Fibrosis; Gene Expression; In Situ Nick-End Labeling; Ki-67 Antigen; Lithiasis; Male; Mucin 5AC; Quinazolines; Rats; Rats, Sprague-Dawley; Recurrence; Tyrphostins | 2011 |
Suppression of proliferative cholangitis in a rat model with direct adenovirus-mediated retinoblastoma gene transfer to the biliary tract.
Topics: Adenoviridae; Animals; Bromodeoxyuridine; Calculi; Cell Division; Cholangitis; Disease Models, Animal; Gene Transfer Techniques; Genes, Retinoblastoma; Genetic Therapy; Humans; Immunohistochemistry; Male; Polymerase Chain Reaction; Rats; Rats, Wistar | 1998 |
Suppression of proliferative cholangitis by E2F decoy oligodeoxynucleotide.
Topics: Animals; Antimetabolites; Bile Ducts; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cholangitis; DNA-Binding Proteins; E2F Transcription Factors; Genetic Therapy; Immunohistochemistry; Liposomes; Luciferases; Male; Oligodeoxyribonucleotides; Plasmids; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Sendai virus; Transcription Factors; Transfection | 2002 |